Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |